Go Back
High-throughput Gene Synthesis Service
In the rapidly evolving field of synthetic biology, the demand for gene synthesis capabilities has become increasingly urgent. At our company, we are proud to offer research customers fast and cost-effective high-throughput gene synthesis services. Our expertise lies in synthesizing large quantities of gene fragments and even long genomic sequences. With our state-of-the-art technology and efficient processes, we are ready to support your research needs and help you accelerate your scientific breakthroughs.
More Details
Description
In the rapidly evolving field of synthetic biology, the demand for gene synthesis capabilities has become increasingly urgent. At our company, we are proud to offer research customers fast and cost-effective high-throughput gene synthesis services. Our expertise lies in synthesizing large quantities of gene fragments and even long genomic sequences. With our state-of-the-art technology and efficient processes, we are ready to support your research needs and help you accelerate your scientific breakthroughs.
Advantages
- Experienced Expert Design Team
- Advanced High-throughput High-fidelity Gene Synthesis Technology
- Seamless and Traceless Cloning Solutions
- Comprehensive Project Management
Deliverable
- 2-5 μg of lyophilized plasmid DNA (low-copy 1-2 μg of lyophilized plasmid DNA)
- Sequencing chromatograms (electronic version in ABI file format)
- Certificate of Analysis (electronic version)
- Gene sequence alignment files (electronic version)
Related:
- Top-notch Grade Plasmid Preparation Service (ET levels ≤0.005 EU/μg)
- Medicine-like Grade Plasmid Preparation Service (ET levels<10 EU/mg)
- Transfection Grade Plasmid Preparation Service (ET levels<100EU/mg)
- Research Grade Plasmid Preparation Service
SBS Genetech is recognized as one of the global major leading industry players in Gene Synthesis by third-party market researchers. For more details, please visit GENE SYNTHESIS MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028).
Only for research and not intended for treatment of humans or animals